# US 2015/0147332 A1 · Bordetella outer-membrane protein antigens and methods of making and using the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0147332 A1
- Document ID: US20150147332A1
- Status: Published application
- Kind: A1
- Application number: 14/498,537
- Filed: 2014-09-26
- Published: 2015-05-28
- Earliest claimed: 2007-10-25
- Assignees: Wake Forest University Health Sciences
- Applicants: Wake Forest University Health Sciences
- Inventors: Rajendar K. Deora; Meenu Mishra; Neelima Sukumar
- Web page: https://patentgrep.com/patent/US20150147332A1

## CPC

- A61K 39/099: {Bordetella}
- A61P 31/04: Antibacterial agents
- A61P 37/04: Immunostimulants
- C07K 14/235: from Bordetella (G)
- C07K 16/1225: {from Bordetella (G)}
- G01N 33/56911: {Bacteria}
- A61K 2039/505: {comprising antibodies}
- A61K 2039/55505: {Inorganic adjuvants}
- A61K 2039/575: {humoral response}
- G01N 2333/235: from Bordetella (G)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

An isolated protein or peptide selected from the group consisting of Bordetella colonization factor A (BcfA) protein and antigenic fragments thereof is described, along with an isolated nucleic acid encoding the same, antibodies that bind to the same, methods of producing an immune response in a mammalian subject in need thereof by administering the proteins, peptides or antibodies, and pharmaceutical compositions comprising the same.

## Claims

### Claim 1

An isolated protein or peptide selected from the group consisting of Bordetella colonization factor A (BcfA) protein and antigenic fragments thereof.

### Claim 2 (depends on 1)

The protein or peptide of claim 1, wherein said BcfA protein has the sequence of SEQ ID NO: 2.

### Claim 3 (depends on 1)

The protein or peptide of claim 1, wherein said protein or peptide is an antigenic fragment of BcfA from 20 to 500 amino acids in length.

### Claim 4 (depends on 1)

The protein or peptide of claim 1, wherein said protein or peptide is an antigenic fragment of BcfA having the sequence given herein as SEQ ID NO: 3 or an antigenic fragment comprising 10 or more contiguous amino acids thereof.

### Claim 5

An isolated nucleic acid that encodes a protein or peptide selected from the group consisting of Bordetella colonization factor A (BcfA) protein and antigenic fragments thereof.

### Claim 6 (depends on 5)

The isolated nucleic acid of claim 5 operatively associated with a promoter.

### Claim 7 (depends on 5)

A host cell that contains an isolated nucleic acid of claim 5 and expresses the encoded protein or peptide.

### Claim 8 (depends on 1)

A method of producing an immune response in a mammalian subject in need thereof, comprising administering said subject a protein or peptide of claim 1 in an amount effective to produce an immune response.

### Claim 9 (depends on 8)

The method of claim 8, wherein said immune response is a protective immune response to Bordetella infection.

### Claim 10 (depends on 9)

The method of claim 9, wherein said Bordetella infection is Bordetella bronchiseptica or Bordetella pertussis infection.

### Claim 11 (depends on 1)

A composition comprising a protein or peptide of claim 1 in a pharmaceutically acceptable carrier.

### Claim 12

An isolated antibody that binds to BcfA protein.

### Claim 13 (depends on 12)

The antibody of claim 12, wherein said antibody is a polyclonal antibody.

### Claim 14 (depends on 12)

The antibody of claim 12, wherein said antibody is a monoclonal antibody.

### Claim 15 (depends on 12)

The antibody of claim 12 coupled to a solid support.

### Claim 16 (depends on 12)

The antibody of claim 12 coupled to a detectable group.

### Claim 17 (depends on 12)

The antibody of claim 12 in a pharmaceutically acceptable carrier.

### Claim 18 (depends on 12)

A method of treating a mammalian subject for a Bordetella infection, comprising administering said subject an antibody of claim 12 in a treatment effective amount.

### Claim 19 (depends on 18)

The method of claim 18, wherein said Bordetella infection is a Bordetella bronchiseptica or Bordetella pertussis infection.

### Claim 20 (depends on 12)

A method of detecting Bordetella in a biological sample, comprising:
contacting said sample to an antibody of claim 12; and then
detecting the presence or absence of specific binding of said antibody to said sample, the presence of specific binding to said sample indicating the presence of Bordetella in said sample.

### Claim 21

(canceled)
